Overview

Efficacy of Ventavis Used in Real-life Setting.

Status:
Completed
Trial end date:
2016-09-22
Target enrollment:
Participant gender:
Summary
This is a registry of patients diagnosed with pulmonary arterial hypertension, scheduled for treatment with Ventavis. Typical clinical measures and quality of life will be prospectively followed in 12 months period.
Details
Lead Sponsor:
Bayer
Treatments:
Iloprost